Analysis of expression of nuclear factor κB (NF-κB) in multiple myeloma: downregulation of NF-κB induces apoptosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of expression of nuclear factor κB (NF-κB) in multiple myeloma: downregulation of NF-κB induces apoptosis

Published:2001-11 Issue:2 Volume:115 Page:279-286
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Ni Hongyu,Ergin Melek,Huang Qin,Qin Jian-Zhong,Amin Hesham M.,Martinez Robert L.,Saeed Shahnaz,Barton Kevin,Alkan Serhan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03102.x/fullpdf

Reference40 articles.

1. Advances in the biology of multiple myeloma: therapeutic applications;Anderson;Seminars in Oncology,1999

2. Constitutive nuclear factor-(B-Rel A activation is required for proliferation and survival of Hodgkin's disease tumor cells;Bargou;Journal of Clinical Investigation,1997

3. Control of apoptosis by Rel/NF-κB transcription factors;Barkett;Oncogene,1999

4. Multiple myeloma;Bataille;New England Journal of Medicine,1997

5. Etiology of multiple myeloma: what's new;Berenson;Seminars in Oncology,1999

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies;Biomedicine & Pharmacotherapy;2023-07

2. Targeting NF ‐κB in Oncology, an Untapped Therapeutic Potential;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

3. Epipolythiodioxopiperazine‐Based Natural Products: Building Blocks, Biosynthesis and Biological Activities;ChemBioChem;2022-09-15

4. MYD88^L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy;THER ADV HEMATOL;2022

5. MYD88^L265Pand CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy;Therapeutic Advances in Hematology;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3